intravitreal, VEGF Therapy, macula


Find the job that’s right for you. PhysiciansJobsPlus allows you to post your resume, receive relevant ophthalmology open position alerts via email and apply for positions online.

Cover Image Not Available

January 2014


Phototherapy for Diabetic Eye Disease
By:  Geoffrey B. Arden, PhD, FRCOphth
We know more than ever before about the relationships among light, hypoxia, and VEGF in diabetic retinopathy.

Economics of Intravitreal Medications For Neovascular AMD
By:  Atul Jain, MD; Neeta Varshney, MD
Cost, VA improvement, and number of treatments factor into a balancing act.

The Role of Pegaptanib In the Treatment of Exudative AMD And Diabetic Retinopathy
By:  Michael J. Tolentino, MD; Michael S. Tolentino
Briefly the standard of care, pegaptanib could find a niche.

Systemic Safety Of Intravitreal VEGF Inhibitors
By:  Usha Chakravarthy, MD, PhD, FRCS, FRCOphth; Christine Rogers, PhD
What concerns remain?

Update on Diagnosis and Treatment Of CMV Retinitis
By:  Nicholas J. Butler, MD; Jennifer E. Thorne, MD, PhD
HAART has decreased the incidence, but a definitive cure remains elusive.

Ten Months to ICD-10: Will Physicians, Vendors and Payers be Ready?
By:  Joseph Burns
Practices are training staff and physicians and meeting with system vendors and health plans as they prepare to use new codes.


By:  Peter K. Kaiser, M.D.
Dollars and Sense

Subspecialty News
By:  Jerry Helzner, Senior Editor
Eylea has positive BRVO trial; QLT begins trial for IDA treatment; Specific biomarker makes GA drug more effective; and more.

Coding Q & A
By:  Riva Lee Asbell
Medicare stepping up audits of 'New Patient' rule

AAO Retina SubDays Detail Up-to-the-Minute Findings
By:  Andrew E. Mathis, PhD, Medical Editor

Controversies in Care
By:  Michael Colucciello, MD
DME: When Should You Initiate Local Treatment?

Focus On
A New Light on Multispectral Imaging